NCT04677426 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study Status WITHDRAWN Phase PHASE2
NCT04643769 Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status SUSPENDED Phase PHASE1
NCT04619199 Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT04614441 NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib Status COMPLETED Phase N/A
NCT04594707 A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE3
NCT04564664 High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA
NCT04552899 A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE3
NCT04541875 Medication Adherence and Non-adherence in Adults With Rare Disease Status WITHDRAWN Phase N/A
NCT04540770 A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 Status COMPLETED Phase PHASE1
NCT04533022 Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF Status COMPLETED Phase PHASE2
NCT04512170 Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT04481074 Inspiratory Muscle Training in Patients With Interstitial Lung Disease Status COMPLETED Phase NA
NCT04430491 To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Status COMPLETED Phase N/A
NCT04429516 Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough Status COMPLETED Phase PHASE3